NCT00228514已完成3 期
Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) PET Sub Study
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- To study the effect of rosuvastatin in Chronic Heart Failure on myocardial perfusion (reserve). Before and 6 months after study medication is started a Positron Emission Tomography (PET-scan) is performed.
研究概览
简要总结
At one site, patients participating in the Corona main study are asked to participate in the PET-substudy. Before and 6 months after study medication is started a Positron Emission Tomography (PET-scan) is performed to study the effect of rosuvastatin in Chronic Heart Failure on myocardial perfusion (reserve)
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 60 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients fulfilling the in and exclusion criteria of the CORONA study and separate informed consent for participation in the sub study.
排除标准
- •See above
结局指标
主要结局
To study the effect of rosuvastatin in Chronic Heart Failure on myocardial perfusion (reserve). Before and 6 months after study medication is started a Positron Emission Tomography (PET-scan) is performed.
次要结局
- To study the effect of rosuvastatin in Chronic Heart Failure on mismatch. Before and 6 months after study medication is started a Positron Emission Tomography (PET-scan) is performed.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Crestor Versus Placebo in Subjects With Heart FailureHeart FailureNCT00206310AstraZeneca5,013
已完成
2 期
Glenohumeral Cortisone InjectionHumeral FracturesNCT04216017University of Washington9
已完成
2 期
Exemestane or Docetaxel-Cytoxan in Low Recurrence Score CancersBreast CancerNCT00941330Emory University31
Unknown
4 期
Study of Statin for Reduction of Postoperative Paroxysmal Atrial FibrillationParoxysmal Atrial FibrillationNCT02502110The Third Xiangya Hospital of Central South University346
Unknown
不适用
Peking and Rotterdam on Mission to Reduce Coronary Artery DiseaseDiabetes MellitusAcute Coronary SyndromeNCT01653119Peking University Third Hospital1,000